Morihito Okada

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +7

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection

Morihito Okada, Wataru Nishio, Toshihiko Sakamoto et al. · Journal of Thoracic and Cardiovascular Surgery · 2004 · 337 citations

Surgical Oncology, Cell Lung Cancer, Lesser Resection +10

Is segmentectomy with lymph node assessment an alternative to lobectomy for non–small cell lung cancer of 2 cm or smaller?

Morihito Okada, Koichi Yoshikawa, Takeshi Hatta et al. · The Annals of Thoracic Surgery · 2001 · 315 citations

Surgical Oncology, Cell Lung Cancer, Medicine +8

Functional Advantage After Radical Segmentectomy Versus Lobectomy for Lung Cancer

Hiroaki Harada, Morihito Okada, Toshihiko Sakamoto et al. · The Annals of Thoracic Surgery · 2005 · 311 citations · Full text

Surgical Oncology, Medicine, Cancer Management +7

Complex permittivities of breast tumor tissues obtained from cancer surgeries

Takumi Sugitani, S. Kubota, Shin-Ichiro Kuroki et al. · Applied Physics Letters · 2014 · 193 citations

Tissue Engineering, Engineering, Cancer Surgeries +17